Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “First or Second Line Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06846346
What this trial is testing

Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma

Who this might be right for
Metastatic Esophageal AdenocarcinomaAdvanced Esophageal AdenocarcinomaMetastatic Gastric Adenocarcinoma+1 more
UNICANCER 88
Not applicableStudy completedNCT05475431
What this trial is testing

Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity

Who this might be right for
Helicobacter Pylori InfectionComorbidities and Coexisting ConditionsReal-world Outcome+3 more
National Cheng-Kung University Hospital 1,053
Not applicableStudy completedNCT06558084
What this trial is testing

Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy

Who this might be right for
Toxicity, DrugProgression, Disease
Ain Shams University 64
Early research (Phase 1)Study completedNCT01764477
What this trial is testing

Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Advanced Pancreatic CancerMetastatic Pancreatic CancerPancreatic Adenocarcinoma
Prism Pharma Co., Ltd. 20
Not applicableUnknownNCT05233358
What this trial is testing

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

Who this might be right for
Hepatocellular Carcinoma
The Central Hospital of Lishui City 176
Testing effectiveness (Phase 2)Study completedNCT02223884
What this trial is testing

Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

Who this might be right for
Malignant Melanoma
Yonsei University 30
Testing effectiveness (Phase 2)Study completedNCT01003964
What this trial is testing

Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV

Who this might be right for
Non Small Cell Lung Cancer
National Cancer Center, Korea 289
Testing effectiveness (Phase 2)Study completedNCT00493636
What this trial is testing

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

Who this might be right for
Breast Cancer
Accelerated Community Oncology Research Network 160
Not applicableStudy completedNCT07537985
What this trial is testing

Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment

Who this might be right for
Hepatocellulcar Carcinoma
Sun Yat-sen University 200
Not applicableStudy completedNCT01225406
What this trial is testing

Third Line Highly Active Antiretroviral Therapy (HAART) in HIV-infected Children

Who this might be right for
This Study is Designed to Collect Treatment Data of Thai Children on Third Line ARV Therapy
The HIV Netherlands Australia Thailand Research Collaboration 56
Early research (Phase 1)Active Not RecruitingNCT03549442
What this trial is testing

Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Pennsylvania 40
Large-scale testing (Phase 3)Ended earlyNCT00968968
What this trial is testing

Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone

Who this might be right for
Cancer
Novartis Pharmaceuticals 37
Early research (Phase 1)Study completedNCT00934882
What this trial is testing

Study to Determine Safety, Pharmacokinetics, Pharmacodynamics of BAY73-4506 in Combination With mFOLFOX6 or FOLFIRI

Who this might be right for
Colorectal Neoplasms
Bayer 45
Testing effectiveness (Phase 2)Looking for participantsNCT05363280
What this trial is testing

Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment

Who this might be right for
Small Cell Lung CancerRenal Cell Carcinoma (RCC)Non-Small Cell Lung
Advenchen Pharmaceuticals, LLC. 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07495579
What this trial is testing

Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Asan Medical Center 146
Testing effectiveness (Phase 2)Ended earlyNCT03807479
What this trial is testing

Study in Patients With Chronic Leukemia

Who this might be right for
Leukemia, Myeloid, Chronic-Phase
GWT-TUD GmbH 18
Large-scale testing (Phase 3)Study completedNCT02259127
What this trial is testing

ODYSSEY (PENTA 20)

Who this might be right for
HIV Infection
PENTA Foundation 792
Testing effectiveness (Phase 2)Looking for participantsNCT03356054
What this trial is testing

Phase I-II Study in CD30 Positive Diffuse Large B-cell Lymphoma Patients Refractory to First Line Chemotherapy or in First Relapse

Who this might be right for
DLBCL
Stichting Hemato-Oncologie voor Volwassenen Nederland 37
Early research (Phase 1)UnknownNCT02280993
What this trial is testing

Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients

Who this might be right for
Hodgkin LymphomaRefractoryRelapse
Marjolein Spiering 72
Early research (Phase 1)Study completedNCT03978689
What this trial is testing

Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerHPV Positive Oropharyngeal Squamous Cell CarcinomaHPV-Related Carcinoma
Cue Biopharma 80
Next Page